Central Pacific Bank - Trust Division’s Haemonetics HAE Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$405K	Sell	5,406 -35	-0.6%	-$2.25K	0.04%	349
2026 Q1	$307K	Sell	5,441 -3,459	-39%	-$225K	0.04%	370
2025 Q4	$713K	Buy	8,900 +188	+2%	+$12.6K	0.09%	240
2025 Q3	$425K	Buy	8,712 +1,089	+14%	+$67.4K	0.05%	312
2025 Q2	$569K	Buy	7,623 +2,988	+64%	+$198K	0.07%	263
2025 Q1	$295K	Buy	4,635 +2,170	+88%	+$148K	0.04%	361
2024 Q4	$192K	Sell	2,465 -300	-11%	-$24.1K	0.03%	456
2024 Q3	$222K	Buy	2,765 +656	+31%	+$53K	0.03%	439
2024 Q2	$174K	Buy	2,109 +468	+29%	+$41.2K	0.02%	578
2024 Q1	$139K	Buy	+1,641	New	+$129K	0.02%	612

Other funds holding HAE

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Central Pacific Bank - Trust Division's HAE Position: Q2 2026 in Review

Central Pacific Bank - Trust Division reduced its Haemonetics (HAE) stake by 0.64% in Q2 2026, selling an estimated $2.25K and leaving 5,406 shares worth $405K. The position accounts for 0.04% of the portfolio, ranked #349.

Central Pacific Bank - Trust Division first reported a position in HAE in Q1 2024 and has held it in 10 quarters since. The position peaked at $713K in Q4 2025. 87 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Central Pacific Bank - Trust Division held 5,406 shares of Haemonetics worth $405K as of Q2 2026.
Central Pacific Bank - Trust Division sold 35 Haemonetics shares in Q2 2026, an estimated $2.25K.
Haemonetics made up 0.04% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #349 holding.
Central Pacific Bank - Trust Division first reported a position in Haemonetics in Q1 2024 and has held it in 10 quarters since.
Central Pacific Bank - Trust Division's Haemonetics position peaked at $713K in Q4 2025.
87 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.